Published in N Engl J Med on January 01, 2009
Deceased Organ Donor Interventions to Protect Kidney Graft Function | NCT02525510
IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol (2009) 2.43
Supercooling enables long-term transplantation survival following 4 days of liver preservation. Nat Med (2014) 2.31
Delayed graft function in the kidney transplant. Am J Transplant (2011) 2.06
Organ procurement and perfusion before transplantation. N Engl J Med (2009) 1.66
Functional tooth regeneration using a bioengineered tooth unit as a mature organ replacement regenerative therapy. PLoS One (2011) 1.17
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15
New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol (2012) 1.11
Current state of hypothermic machine perfusion preservation of organs: The clinical perspective. Cryobiology (2009) 1.11
The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. J Pharmacol Exp Ther (2010) 1.05
Preimplant histologic acute tubular necrosis and allograft outcomes. Clin J Am Soc Nephrol (2014) 1.04
Preservation methods for kidney and liver. Organogenesis (2009) 1.03
Recent developments in kidney transplantation--a critical assessment. Am J Transplant (2009) 1.02
Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. J Am Soc Nephrol (2013) 1.01
Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol (2011) 0.99
Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med (2014) 0.98
Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother (2011) 0.98
Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation (2010) 0.97
Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) (2010) 0.97
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant (2012) 0.94
Primary graft failure after heart transplantation. J Transplant (2011) 0.93
Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant (2015) 0.90
Associations of deceased donor kidney injury with kidney discard and function after transplantation. Am J Transplant (2015) 0.90
Glutathione S-transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function. Am J Transplant (2014) 0.87
Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol (2015) 0.86
Expanding the pool of kidney donors: use of kidneys with acute renal dysfunction. Einstein (Sao Paulo) (2015) 0.84
Uncontrolled donors with controlled reperfusion after sixty minutes of asystole: a novel reliable resource for kidney transplantation. PLoS One (2013) 0.84
Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One (2013) 0.84
The role of innate immunity in donor organ procurement. Semin Immunopathol (2011) 0.83
Progress in abdominal organ transplantation. Med Sci Monit (2011) 0.81
Mechanisms and consequences of injury and repair in older organ transplants. Transplantation (2014) 0.80
Assessing viability of extracorporeal preserved muscle transplants using external field stimulation: a novel tool to improve methods prolonging bridge-to-transplantation time. Sci Rep (2015) 0.80
MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys. PLoS One (2012) 0.80
Changing pattern of organ donation and utilization in the USA. Int J Organ Transplant Med (2012) 0.79
Analysis of machine perfusion benefits in kidney grafts: a preclinical study. J Transl Med (2011) 0.79
Mouse IPK: A Powerful Tool to Partially Characterize Renal Reperfusion and Preservation Injury. Open Transplant J (2011) 0.79
Organomatics and organometrics: Novel platforms for long-term whole-organ culture. Technology (Singap World Sci) (2014) 0.79
Hypothermic Perfusion Preservation of Pancreas for Islet Grafts: Validation Using a Split Lobe Porcine Model. Cell Med (2012) 0.78
Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model. J Transl Med (2012) 0.78
Hypothermic machine perfusion reduces delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis. PLoS One (2013) 0.78
Acute kidney injury: preclinical innovations, challenges, and opportunities for translation. Can J Kidney Health Dis (2015) 0.78
From six thousand transaminases level to three hundred after liver transplantation: a new era seems to be open. Updates Surg (2017) 0.78
Metabolomic perfusate analysis during kidney machine perfusion: the pig provides an appropriate model for human studies. PLoS One (2014) 0.77
Challenges in machine perfusion preservation for liver grafts from donation after circulatory death. Transplant Res (2013) 0.77
Persufflation (or gaseous oxygen perfusion) as a method of organ preservation. Cryobiology (2012) 0.77
Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation? J Transl Med (2016) 0.77
Technical feasibility of liver transplantation without cold storage. Langenbecks Arch Surg (2013) 0.77
Persufflation (gaseous oxygen perfusion) as a method of heart preservation. J Cardiothorac Surg (2013) 0.77
Organ preservation using a photosynthetic solution. Transplant Res (2012) 0.77
Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation. Curr Transplant Rep (2014) 0.77
Development of pancreas storage solutions: Initial screening of cytoprotective supplements for β-cell survival and metabolic status after hypothermic storage. Biopreserv Biobank (2013) 0.77
Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms. Einstein (Sao Paulo) (2015) 0.77
The value of machine perfusion in deceased donor kidney transplantation. Am J Kidney Dis (2009) 0.76
Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2009) 0.76
Hypothermic machine perfusion increases A20 expression which protects renal cells against ischemia/reperfusion injury by suppressing inflammation, apoptosis and necroptosis. Int J Mol Med (2016) 0.76
The impact of vascular anastomosis time on early kidney transplant outcomes. Transplant Res (2013) 0.76
Does kidney transplantation with deceased or living donor affect graft survival? Nephrourol Mon (2014) 0.76
Strategies to rescue steatotic livers before transplantation in clinical and experimental studies. World J Gastroenterol (2013) 0.76
Flow is critical for maintaining a protective phenotype in renal proximal tubular cells. Am J Transplant (2013) 0.76
(13)C glucose labelling studies using 2D NMR are a useful tool for determining ex vivo whole organ metabolism during hypothermic machine perfusion of kidneys. Transplant Res (2016) 0.75
Protective mechanisms of hypothermia in liver surgery and transplantation. Mol Med (2015) 0.75
Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun (2017) 0.75
A case of kidney transplantation using donation after circulatory death with renal calculi. Int J Clin Exp Med (2015) 0.75
Machine Perfusion of Porcine Livers with Oxygen-Carrying Solution Results in Reprogramming of Dynamic Inflammation Networks. Front Pharmacol (2016) 0.75
Protective effect of zinc-N-acetylcysteine on the rat kidney during cold storage. Am J Physiol Renal Physiol (2013) 0.75
Organ protective mechanisms common to extremes of physiology: a window through hibernation biology. Integr Comp Biol (2014) 0.75
Current status of vascularized composite tissue allotransplantation. Burns Trauma (2014) 0.75
Utility of applying quality assessment tools for kidneys with KDPI ≥80. Transplantation (2016) 0.75
Beyond poiseuille: preservation fluid flow in an experimental model. J Transplant (2013) 0.75
Challenges and advances in optimizing liver allografts from donation after circulatory death donors. J Nat Sci Biol Med (2016) 0.75
Machine perfusion in solid organ transplantation: where is the benefit? Langenbecks Arch Surg (2014) 0.75
Ex-vivo perfusion machines in kidney transplantation. The significance of the resistivity index. Clujul Med (2014) 0.75
Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation. PLoS One (2012) 0.75
Optimizing Graft Survival by Pretreatment of the Donor. Clin J Am Soc Nephrol (2017) 0.75
Delayed graft function phenotypes and 12-month kidney transplant outcomes. Transplantation (2016) 0.75
A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011. Clin J Am Soc Nephrol (2012) 0.75
Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases. PLoS One (2016) 0.75
Survey of Apoptosis After Hypothermic Storage of a Pancreatic β-Cell Line. Biopreserv Biobank (2016) 0.75
Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol. World J Transplant (2017) 0.75
Controlled Rewarming after Hypothermia: Adding a New Principle to Renal Preservation. Clin Transl Sci (2015) 0.75
Kidney donation after cardiac death. World J Nephrol (2012) 0.75
Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol. J Vis Exp (2016) 0.75
Transplantation: Pump it up: conserving a precious resource? Nat Rev Nephrol (2009) 0.75
Hypothermic Machine Perfusion Preservation of the DCD Kidney: Machine Effects. J Transplant (2013) 0.75
Maximizing kidneys for transplantation using machine perfusion: from the past to the future: A comprehensive systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Delayed graft function and its management in children. Pediatr Nephrol (2016) 0.75
Transplantation in autosomal recessive polycystic kidney disease: liver and/or kidney? Pediatr Nephrol (2014) 0.75
Comparison of normothermic and hypothermic perfusion in porcine kidneys donated after cardiac death. J Surg Res (2017) 0.75
Role of temperature in reconditioning and evaluation of cold preserved kidney and liver grafts. Curr Opin Organ Transplant (2017) 0.75
Ischaemic and inflammatory injury in renal graft from brain death donation: an update review. J Anesth (2016) 0.75
Randomized Trial of Machine Perfusion Versus Cold Storage in Recipients of Deceased Donor Kidney Transplants With High Incidence of Delayed Graft Function. Transplant Direct (2017) 0.75
Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70
Intrarenal resistive index after renal transplantation. N Engl J Med (2013) 4.19
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA (2009) 3.83
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24
Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol (2010) 2.71
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology (2010) 2.60
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology (2012) 2.49
Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am J Transplant (2005) 2.46
Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis (2011) 2.38
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int (2011) 2.25
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut (2013) 2.10
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics (2004) 2.06
One or 4 h of "in-house" reconditioning by machine perfusion after cold storage improve reperfusion parameters in porcine kidneys. Transpl Int (2014) 2.00
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93
Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl (2002) 1.79
The need for interval appendectomy after resolution of an appendiceal mass questioned. Dig Surg (2002) 1.78
Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76
Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg (2009) 1.76
Congenital veno-venous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol (2007) 1.68
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Perspectives in organ preservation. Transplantation (2007) 1.63
The histology of kidney transplant failure: a long-term follow-up study. Transplantation (2014) 1.61
AMP-activated protein kinase as a target for preconditioning in transplantation medicine. Transplantation (2010) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Outcome of the living kidney donor. Nephrol Dial Transplant (2012) 1.57
Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant (2008) 1.56
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept. Transplantation (2016) 1.54
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer (2010) 1.51
Kidney donation from children after cardiac death. Crit Care Med (2010) 1.50
Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function. Crit Care Med (2010) 1.50
Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47
Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46
Troponin I is a predictor of acute cardiac events in the immediate postoperative renal transplant period. Transplantation (2010) 1.45
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. Transplantation (2015) 1.44
Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship. Transplantation (2006) 1.44
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation (2004) 1.44
Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology (2011) 1.43
Thirty-seven patients treated with the C-seal: protection of stapled colorectal anastomoses with a biodegradable sheath. Int J Colorectal Dis (2013) 1.43
Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant (2004) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Lipid peroxidation products in machine perfusion of older donor kidneys. J Surg Res (2012) 1.42
The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability. Liver Transpl (2008) 1.41
Does PEEP impair the hepatic outflow in patients following liver transplantation? Intensive Care Med (2006) 1.41
How important is the duration of the brain death period for the outcome in kidney transplantation? Transpl Int (2010) 1.40
Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation. Pediatr Transplant (2006) 1.39
Nonesterified fatty acids and development of graft failure in renal transplant recipients. Transplantation (2013) 1.39
Outcome after kidney transplantation in children with thrombotic risk factors. Pediatr Transplant (2006) 1.39
Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation (2009) 1.38
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg (2005) 1.32
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol (2006) 1.32
Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion (2007) 1.31
Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg (2003) 1.31
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol (2013) 1.28
Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2012) 1.26
Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg (2009) 1.25
Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol (2009) 1.25
The phenomenon of infection with abdominal wall reconstruction. Biomaterials (2007) 1.24
Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int (2006) 1.24
Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int (2004) 1.22
Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology (2010) 1.22
Major bile duct injuries after laparoscopic cholecystectomy: a tertiary center experience. J Gastrointest Surg (2004) 1.21
Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function. Clin J Am Soc Nephrol (2010) 1.21
Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl (2006) 1.20
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg (2006) 1.20
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation (2005) 1.17
Laparoscopic inguinal hernia repair as a potential complicating factor in kidney transplantation. Transplantation (2005) 1.17
Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg (2010) 1.17